Indian generics major Cipla has unveiled plans to invest £100 million in the UK as it looks to expand its global footprint.
The deal was announced by Chancellor of the Exchequer George Osborne (pictured) who is on a trade mission to India, stating that the investment will fund the launch of a range of drugs in the areas of respiratory, oncology and antiretroviral medicines. He added that the cash will also be used on R&D, clinical trials “and further expansion internationally and in the UK”.
Read more at: http://www.pharmatimes.com/Article/14-07-07/India_s_Cipla_to_invest_%C2%A3100_million_in_the_UK.aspx#ixzz36wQ9kz6k
Filed under: COMPANIES Tagged: CIPLA, UK
